A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
NCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…
Read more arrow_forwardNCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…
Read more arrow_forwardNCT 04516447 Brief Summary This is a Phase 1b open-label, multicenter study,…
Read more arrow_forwardNCT 07059845 Brief Summary Ovarian cancer is a lethal disease with an…
Read more arrow_forwardNCT 05503797 Brief Summary The objective of this Master Protocol is to…
Read more arrow_forwardNCT 05205109 Brief Summary This is a study of ATG-037 Monotherapy and…
Read more arrow_forwardNCT 06179160 Brief Summary This study is conducted to determine the safety…
Read more arrow_forwardNCT 04913285 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 07115043 Brief Summary A Study to Investigate Safety of AZD6750 in…
Read more arrow_forwardNCT 06326411 Brief Summary This is a two-part Phase 1, open label,…
Read more arrow_forwardNCT 06710847 Brief Summary Solid tumours are abnormal lumps of tissue that…
Read more arrow_forward